What is Prestige Consumer Healthcare's thereafter?

Prestige Consumer Healthcare (PBH) reported thereafter of $600M in Q4 2025.

How has Prestige Consumer Healthcare's thereafter changed year-over-year?

Prestige Consumer Healthcare's thereafter decreased by 0.0% year-over-year, from $600M to $600M.

Revenue$281.6M-5.0%

Gross profit$146.3M-13.9%

Operating income$75.5M-14.6%

Net income$53.9M+7.6%

EPS (diluted)$1.13+11.9%

Cash & equivalents$63.9M-34.8%

Total debt$1.0B-0.2%

Total equity$1.9B+2.9%

Total assets$3.5B+2.7%

Operating cash flow$42.8M-30.7%

CapEx$5.2M+49.8%

Free cash flow$37.6M-35.5%

Market cap$2.24B-34.1%

Gross margin54.7%-1.1pp

Operating margin28.4%-1.2pp

Net margin17.5%-1.4pp

FCF margin22.6%+1.3pp

Return on equity10.2%-2.1pp

Debt / equity0.6×0.0×

Current ratio3.6×-0.6×

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept pbh:LongTermDebtMaturityAfterYearFour.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

What is Prestige Consumer Healthcare's thereafter?: Prestige Consumer Healthcare (PBH) reported thereafter of $600M in Q4 2025.
How has Prestige Consumer Healthcare's thereafter changed year-over-year?: Prestige Consumer Healthcare's thereafter decreased by 0.0% year-over-year, from $600M to $600M.